ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

About Face; NCI To Keep Preclinical AIDS Drug Development

December 12, 1986

NCI Funding Notice.

July 4, 2003

In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving

December 6, 1996

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011

MSK Withdraws Form Breast Cancer Nutrition Study Over Chemotherapy Issue; Program Still “Going Well”

June 21, 1985

DCT Advisers Ok Expansion of Phase 1, Phase 2 Testing

July 10, 1992